| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | RR5U4UFJ8L |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1864871-20-4 |
| ChEMBL | CHEMBL4297891 |
| FDA SRS | RR5U4UFJ8L |
| Guide to Pharmacology | 9778 |
CONTENTS